Evidence map›Paper›PMID 40959702›Full record

ArticleFrontiers in nutrition2025

Effects of

Wenjing Ji, Delphine Marie Saulnier, Lan Zhang, Jingxia Liu, Jisheng Gao, Xia Wang, Caterina Holz, Aimin Liang, Hern-Tze Tina Tan

Registry-linked trialAbstract read
In one paragraph

Article in Frontiers in nutrition, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04891666 (A Clinical Trial to Evaluate the Efficacy and Safety of Lactobacillus Plantarum DSM 33464), which is not on this map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04891666 nacompletednot on this map

A Clinical Trial to Evaluate the Efficacy and Safety of Lactobacillus Plantarum DSM 33464 (SmartGuard®) on Blood Lead Levels in Children

TypeinterventionalSponsorNovozymes A/SRan2021 to 2023Enrolled66ConditionsElevated Blood Lead LevelsArmsLactobacillus plantarum DSM 33464, Placebo
3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Wenjing Ji *Department of Children's Health Care Center, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China.
Delphine Marie Saulnier *Novozymes Berlin GmbH, Berlin, Germany.
Lan ZhangChengdu Women's and Children's Central Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China.
Jingxia LiuBaoding Children's Hospital, Baoding, China.
Jisheng GaoXuzhou Children's Hospital, Xuzhou, China.
Xia WangChildren's Hospital of Hebei Province, Hebei, China.
Caterina HolzNovozymes Berlin GmbH, Berlin, Germany.
Aimin LiangDepartment of Children's Health Care Center, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China.
Hern-Tze Tina TanNovonesis, Cork, Ireland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Approximately one-third of the world's children have elevated blood lead levels (BLLs), which may lead to often-irreversible decreased intelligence, behavioral difficulties, and learning problems. Identification and removal of the source of lead, along with good nutrition, are the only advocated initial management, with chelation therapy for higher threshold BLLs. Probiotics have shown promising beneficial effects pre-clinically. Here, we investigated the safety and efficacy of the probiotic Methods: Children aged 3-12 years with elevated BLLs (>3.5 μg/dL) were enrolled in a randomized double-blind placebo-controlled multi-centered study and received either probiotic (1 × 10 Results: Overall, 66 children were randomized, 54 received intervention (probiotic; Conclusion: This study adds to previous findings suggesting that probiotic intervention may be a promising additional strategy to help reduce BLLs and their detrimental effects in children. Due to the preliminary nature of this study, larger studies investigating the effects of the strain alone, with a longer intervention period, are warranted to confirm the benefits observed. Clinical trial registration: Clinicaltrials.gov, identifier NCT04891666.

Indexed as

abdominal painblood lead levelschildrendevelopmental healthmultivitamin and mineral supplementprobiotic

Identifiers

PMID40959702
PMCPMC12434113

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.